|
About the Confirmatory Testing category -Please read before posting
|
|
1
|
706
|
March 30, 2025
|
|
Solution stability of NDSRI
|
|
7
|
207
|
May 14, 2026
|
|
N-Nitroso Metamizole Impurity C
|
|
4
|
308
|
May 13, 2026
|
|
N-Nitroso Desethyl Amiodarone in Amiodarone HCl Tablets by LC-MS/MS Metodu
|
|
2
|
115
|
May 12, 2026
|
|
Diluent Selection for Nitrosamine Impurities
|
|
7
|
261
|
May 8, 2026
|
|
How to overcome blank interference at NDBA
|
|
4
|
163
|
April 27, 2026
|
|
N Nitroso Tadalfil
|
|
10
|
791
|
April 27, 2026
|
|
Nitrosamines: Mass Spectrometry-Based Analytical Procedures Criterias
|
|
9
|
4292
|
April 24, 2026
|
|
Maximum Daily Dose (MDD) of Cream Formulation
|
|
1
|
163
|
April 17, 2026
|
|
N-Nitroso meglumine
|
|
27
|
2183
|
April 15, 2026
|
|
MDD for cream formulation
|
|
0
|
87
|
April 3, 2026
|
|
N-nitroso-Furosemide
|
|
2
|
489
|
March 31, 2026
|
|
Analysis method of cream
|
|
6
|
259
|
March 30, 2026
|
|
Optimized UHPLC–Derivatization Method for Low-Level Nitrite Detection in Pharmaceutical Excipients-Pub
|
|
0
|
202
|
March 23, 2026
|
|
How to Validate High-Resolution Mass Spectrometry for Nitrosamine Detection in Pharmaceuticals
|
|
3
|
357
|
March 21, 2026
|
|
Minimizing in Source Fragmentation for Mass Spectrometry Based NDSRI Analytical Procedures: A Case Study of Nitroso-bumetanide -Pub
|
|
4
|
314
|
March 19, 2026
|
|
Differences in Physical Form of Nitrosamine Reference Standards: USP vs. Other Suppliers
|
|
2
|
159
|
March 18, 2026
|
|
Scientific Clarification Request on Analytical Approach for Nitrosamine Determination in Quetiapine Oral Suspension
|
|
3
|
235
|
March 17, 2026
|
|
Challenges in developing an analytical method for N‑nitroso‑ambroxol -
|
|
1
|
147
|
March 14, 2026
|
|
Testing of N-nitroso-cinacalcet
|
|
8
|
1034
|
March 14, 2026
|
|
Navigating the complexities in characterization of NDSRIs using advanced analytical techniques-Pub
|
|
2
|
239
|
March 12, 2026
|
|
Challenges in developing an analytical method for N‑nitroso‑ambroxol
|
|
3
|
217
|
March 11, 2026
|
|
Nitrosamine analysis in suspension dosage forms
|
|
5
|
272
|
March 6, 2026
|
|
N-Nitrosodibenzylamine infusion bags
|
|
0
|
121
|
February 27, 2026
|
|
Moxonidine Nitrosamines
|
|
6
|
274
|
February 25, 2026
|
|
N-nitroso-rivaroxaban amide
|
|
7
|
1967
|
February 4, 2026
|
|
Sufentanil Nitroso impurity standard
|
|
8
|
235
|
January 29, 2026
|
|
If NDSRIs are not detected at end of stability, is small-molecule nitrosamine testing still required?
|
|
5
|
262
|
January 23, 2026
|
|
Nitrosamine Impurities: The Analytical & Regulatory Roadmap (2024-2025)
|
|
0
|
408
|
January 20, 2026
|
|
Nitrosamines in macrocyclic antibiotics
|
|
2
|
239
|
December 10, 2025
|